I have been in the same boat for 5 years now, ridden the peaks and troughs.
I am also in the industry for 20 years and work overseas in Europe,so have been through a lot of clinical trials (successes as well as failures) its important to remember delays are usual and mostly not bad news (bad news needs o be reported quickly for the sake of the patients,regulators and the physicians.)Management may simply be in a position where they can't report anything at the moment to the outside world.
The other point of encouragement is that the new Chairman is highly credible within the industry from a global perspective. He is not a light weight and by taking this position he has to be fairly confident it isn't going to fall apart within 6 months (not good on his CV). the timing of his placement is pivotal in my opinion.
- Forums
- ASX - By Stock
- TSN
- risk analysis
risk analysis, page-15
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable